The Swedish CArdioPulmonary bioImage Study – SCAPIS – is a nationwide, open-access, population-based cohort for the study of cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD).
The aim is to predict and prevent cardiovascular and pulmonary disease. A total of 30,154 men and women in Sweden, from 50 to 64 years old, have been recruited and investigated with detailed imaging and functional analyses of the cardiovascular and pulmonary systems. The first public release of data was on March 17, 2021. All researchers based in Sweden, or international researchers in collaboration with an applicant based in Sweden, are welcome to apply for data.
SCAPIS 2 – re-examination
A re-examination of the study participants in SCAPIS is currently being planned. The purpose of SCAPIS 2 is to re-examine half of these study participants, a total of 15,000, at all sites, which will provide a unique opportunity to follow the participants' health. The study will start in January 2024.